Evox Therapeutics Competitors and Similar CompaniesClear all

Evox Therapeutics's competitors and similar companies include Protalex, Biocept, Exosome Diagnostics and Codiak Biosciences.

	Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.	Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.	Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.	Exosome Diagnostics Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date	Founding Date 2016	Founding Date 1999	Founding Date 1993	Founding Date 2008	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare bioengineering biotech drug development genetics nanotech pharma therapy	Tags Healthcare biotech clinical research medtech pharma	Tags Healthcare biotech medical diagnostics oncology	Tags Healthcare biotech clinical research genetics medical diagnostics	Tags Healthcare biotech therapy
Locations	Locations Oxford, GB HQ	Locations Florham Park, US HQ	Locations San Diego, US HQ	Locations Waltham, US HQ Martinsried, DE Athens, US Huntsville, US Mobile, US Montgomery, US Opelika, US see more	Locations Cambridge, US HQ
Employees	Employees 452% decrease	Employees 233% decrease	Employees 878% decrease	Employees 992% decrease	Employees 992% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 615.2 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $25.9m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $22.9m (FY, 2021)
Net income	Net income N/A	Net income ($5m) (FY, 2018)	Net income ($32.1m) (FY, 2022)	Net income N/A	Net income ($37.2m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 158.6m	Total funding raised N/A	Total funding raised $ 15.9m	Total funding raised $ 112.1m	Total funding raised $ 168.5m

For sources of this data, please see the company profile

View Company Profiles

Protalex

Florham Park, US

Employees

2↓ 33% decrease

Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.

View company

Biocept

San Diego, US

Employees

87↓ 8% decrease

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.

View company

Exosome Diagnostics

Waltham, US

Employees

99↓ 2% decrease

Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.